Canaccord Genuity reiterated a Buy rating and boosted its price target on Actavis (NYSE: ACT) to $352.00 (from $300.00)

For an analyst ratings summary and ratings history on Actavis click here. For more ratings news on Actavis click here.

Shares of Actavis closed at $284.00 yesterday.